AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Vitrafy Life Sciences Ltd

3.270

-0.230-6.57%

Volume:17.96K

Turnover:59.81K

Market Cap:249.03M

PE:-12.99

High:3.440

Open:3.440

Low:3.260

Close:3.500

52wk High:4.660

52wk Low:1.200

Shares:76.16M

Float Shares:33.74M

Volume Ratio:0.48

T/O Rate:0.05%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.252

EPS(LYR):-0.252

ROE:-46.29%

ROA:-27.94%

PB:6.06

PE(LYR):-12.99

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Vitrafy Life Sciences Says CEO Agrees to US Move

MT Newswires Live

Vitrafy Life Sciences Ltd-Change to CEO Remuneration and Employment Terms

THOMSON REUTERS

Australia's Vitrafy Life Sciences Heads for Best Day in 2 Months on Versiti Deal

Vitrafy Life Sciences Partners With Versiti Blood Health to Develop End-to-End Platelet Deep-Freezing Technology

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.tigrgood.cn/stock/VFY.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"VFY.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"VFY.AU\",,,,,undefined,":{"symbol":"VFY.AU","market":"AU","secType":"STK","nameCN":"Vitrafy Life Sciences Ltd","latestPrice":3.27,"timestamp":1791433897484,"preClose":3.5,"halted":0,"volume":17964,"delay":0,"changeRate":-0.06571428571428571,"nameEN":"Vitrafy Life Sciences Ltd","floatShares":33735952,"shares":76157278,"eps":-0.2518,"marketStatus":"Trading","change":-0.23,"latestTime":"10-08 15:36:07 AEDT","open":3.44,"high":3.44,"low":3.26,"amount":59810,"amplitude":0.051429,"askPrice":3.28,"askSize":70,"bidPrice":3.26,"bidSize":667,"shortable":3,"etf":0,"ttmEps":-0.2518,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1791435600000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":3.5,"openAndCloseTimeList":[[1791414000000,1791435600000]],"volumeRatio":0.480524,"lotSize":0,"tradeCurrency":"AUD","auctionPricing":{"symbol":"VFY.AU","preClose":3.51,"auctionPrice":3.5,"auctionVolume":1304,"auction":3,"marketStatus":"盘后竞价","timestamp":1791349793877}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"VFY.AU\",,,,,undefined,":{"symbol":"VFY.AU","floatShares":33735952,"roa":"-27.94%","roe":"-46.29%","lyrEps":-0.2518,"volumeRatio":0.480524,"shares":76157278,"dividePrice":0,"high":3.44,"amplitude":0.051429,"preClose":3.5,"low":3.26,"week52Low":1.2,"pbRate":"6.06","psRate":"1191.57","week52High":4.66,"institutionHeld":0,"latestPrice":3.27,"committee":0.810041,"eps":-0.2518,"divideRate":0,"volume":17964,"delay":0,"ttmEps":-0.2518,"open":3.44,"prevYearClose":1.28,"prevWeekClose":3.56,"prevMonthClose":4,"prevQuarterClose":4,"fiveDayClose":3.87,"twentyDayClose":3.67,"sixtyDayClose":2.84},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/VFY.AU\",params:#limit:5,,,undefined,":[{"date":"2026-08-04","symbol":"VFY.AU","type":"earning","reportTimeType":"pre","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1785801600000,"name":null,"time":"Pre-MKt","dateTimestamp":1785765600000,"actualEps":null},{"date":"2026-04-28","symbol":"VFY.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1777334400000,"name":null,"time":"","dateTimestamp":1777298400000,"actualEps":null},{"date":"2026-02-03","symbol":"VFY.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1770073200000,"name":null,"time":"","dateTimestamp":1770037200000,"actualEps":null},{"date":"2025-10-21","symbol":"VFY.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1761001200000,"name":null,"time":"","dateTimestamp":1760965200000,"actualEps":null},{"date":"2025-08-05","symbol":"VFY.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1754352000000,"name":null,"time":"","dateTimestamp":1754316000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"VFY.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"VFY.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2673061221","title":"Vitrafy Life Sciences Says CEO Agrees to US Move","url":"https://stock-news.laohu8.com/highlight/detail?id=2673061221","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673061221?lang=en_us&edition=fundamental","pubTime":"2026-10-07 09:06","pubTimestamp":1791335181,"startTime":"0","endTime":"0","summary":"Vitrafy Life Sciences  said its Managing Director and Chief Executive Officer, Brent Owens, agreed to relocate to Colorado, and that his employment and remuneration arrangements were revised, according to a Wednesday ASX filing.Owens will begin employment under a US-based employment contract with the firm's subsidiary, Vitrafy Life Sciences, Inc, with effect from Nov. 1.The board had determined that the firm's next phase of growth would benefit from the Group CEO role being based permanently in the US.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["VFY.AU","BK7048"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673065063","title":"Vitrafy Life Sciences Ltd-Change to CEO Remuneration and Employment Terms","url":"https://stock-news.laohu8.com/highlight/detail?id=2673065063","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673065063?lang=en_us&edition=fundamental","pubTime":"2026-10-07 05:21","pubTimestamp":1791321715,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261006:nTUE6S5KP9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7048","VFY.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671220023","title":"Australia's Vitrafy Life Sciences Heads for Best Day in 2 Months on Versiti Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2671220023","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671220023?lang=en_us&edition=fundamental","pubTime":"2026-09-30 13:39","pubTimestamp":1790746778,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Vitrafy Life Sciences heads for best day in 2 months onVersiti deal** Shares of Vitrafy Life SciencesVFY.AXgain as much as 13% to A$3.880, headed for their best session since July 29*","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nL4N45M0BI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7048","VFY.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671245282","title":"Vitrafy Life Sciences Partners With Versiti Blood Health to Develop End-to-End Platelet Deep-Freezing Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2671245282","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671245282?lang=en_us&edition=fundamental","pubTime":"2026-09-30 10:49","pubTimestamp":1790736552,"startTime":"0","endTime":"0","summary":"Vitrafy Life Sciences  partnered with Versiti Blood Health, a US non-profit blood network, to advance the development of its cryopreservation ecosystem for platelets, an end-to-end technology for deep-freezing platelets, according to a Wednesday Australian bourse filing.The company said the partnership follows its in-vitro platelet study with the US Army Institute of Surgical Research and will also support verification and validation activities associated with Vitrafy's planned US medical device listing.Under the partnership, Vitrafy and Versiti will each contribute resources to advance development of the no-wash platelet cryopreservation ecosystem within Versiti's platelet workflows, the filing added.Vitrafy's shares fell 2% in recent Wednesday trade.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["VFY.AU","BK7048"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":7,"pageCount":1,"totalSize":26,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/VFY.AU\",params:#limit:6,delay:true,,,undefined,":[]}}